-
Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
PALMA DE MALLORCA, Spain, July 24, 2026 /PRNewswire/ — Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV) in the company’s Phase 2b/3 clinical trial of its lead asset, LAM561, in patients with newly diagnosed…
-
Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma
July 22, 2026 02:00 ET | Source: Healx Cambridge, UK – 22 July, 2026 – Healx, an AI-powered, clinical-stage biotech company dedicated to rare diseases, today announced that the first patient has been dosed in its Phase 1/2 dose-escalation and dose-confirmation clinical trial to evaluate the safety and efficacy of HLX-4310, an investigational oral combination…
-
World’s First International Patient Begins Treatment with Newly Approved Solid Tumor CAR-T Therapy at Jiahui International Cancer Center
SHANGHAI, July 6, 2026 /PRNewswire/ — Jiahui International Cancer Center (JICC) has welcomed the world’s first international patient to begin treatment with Satri-cel, the world’s first approved CAR-T therapy for a solid tumor, marking a historic milestone in expanding global access to China’s latest oncology innovations. Josh, a 59-year-old patient from New Zealand with advanced…
-
Doctors at HCMCT Manipal Hospital Dwarka perform a life-saving heart bypass and robotic lung cancer surgery in a single session
NEW DELHI, June 25, 2026 /PRNewswire/ — Doctors at HCMCT Manipal Hospital Dwarka successfully performed a rare life-saving procedure on a 66-year-old man diagnosed with both coronary artery disease and lung cancer. While being examined for the cancer, the patient reported constant breathlessness and was found to have severe blockages in the arteries, along with cancer…
-
Frost & Sullivan Identifies Virtual Healthcare Assistants as a Transformational Force in Healthcare Delivery
New analysis highlights significant growth opportunities in patient- and clinician-facing AI assistants as healthcare organizations seek to improve efficiency, patient engagement, and care outcomes LONDON, June 18, 2026 /PRNewswire/ — Frost & Sullivan’s latest analysis, Innovations and Growth Opportunities in Virtual Healthcare Assistants, finds that artificial intelligence-powered virtual healthcare assistants are poised to transform healthcare delivery…
-
APAC healthcare systems face growing strain as rising patient expectations collide with stretched clinical workforce – Bain & Company survey
95% of consumers want a single touchpoint to manage their healthcare 84% of consumers expect greater convenience from healthcare system Three in four consumers comfortable with AI-enabled healthcare apps One in five doctors actively considering leaving their current employer due to burnout SINGAPORE, June 17, 2026 /PRNewswire/ — Asia-Pacific healthcare systems are facing growing strain…
-
World Regional Anaesthesia and Pain Medicine day Workshop brings the Spotlight on Strengthening Patient Safety Standards
New Delhi, Delhi, India BD (Becton, Dickinson and Company) recently participated as Knowledge Partner at the World Regional Anaesthesia & Pain Medicine (RAPM) Day Workshop. With the objective of reinforcing patient-safety practices in Regional Anaesthesia, BD India/South Asia focused on enabling real-time, hands-on learning for clinicians to advanced spinal anaesthesia solutions and supporting faculty-led live…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.